Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Result of General Meeting
-
dvm360® unveils 2025–2026 Editorial Advisory Board: Fresh perspectives spark innovation across the veterinary field
-
Microchip Technology Appoints Long-Time TSMC Executive Rick Cassidy to Its Board of Directors
-
COMSTOCK RESOURCES, INC. ANNOUNCES DUAL LISTING ON NYSE TEXAS
-
Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 1Q25
-
NXP Announces Availability of Proxy Materials for the Annual General Meeting of Shareholders to Be Held on June 11, 2025
-
Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications
-
XRP News: Buy $XDX Tokens Now Before XenDex Presale Ends Soon, as XRP Market Heats Up
-
Update on Market Making Arrangements
-
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
-
Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025
-
NurExone Expands European Engagement with Investor Events in Germany and Switzerland
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
-
Taitron Announces Quarterly Cash Dividend
-
Cipher Mining Announces April 2025 Operational Update
-
U.S. Global Investors Announces Third Quarter of Fiscal 2025 Webcast
-
Concorde International Group Announces Underwriter’s Full Exercise and Closing of Over-allotment Option
-
Copley Acquisition Corp Announces Closing of $172,500,000 Initial Public Offering
-
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Greenlight Capital Re, Ltd. Schedules First Quarter 2025 Financial Results and Conference Call
-
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
-
Premium Global Income Split Corp. Declares Monthly Distribution
-
Premium Income Corporation Announces Monthly Distribution
-
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
-
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
-
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Subsea7 awarded ‘super-major’ contract offshore Brazil
-
Silvercrest Asset Management (SAMG) to Announce First Quarter 2025 Results and Host Investor Conference Call
-
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
-
National Healthcare Properties Announces Release Date for First Quarter 2025 Results
-
HPU Honors Graduate Students at Commencement
-
A new MEI study highlights the importance of micro-entrepreneurs in supplying drinking water to poorer neighbourhoods in Ivory Coast
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Republic Digital Acquisition Company Completes $300,000,000 Initial Public Offering
-
Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call
-
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
-
GFG Closes Oversubscribed Financing
-
Great Elm Group, Inc. Schedules Fiscal 2025 Third Quarter Conference Call and Webcast
-
CN Announces Election of Directors
-
Resolution Financial Advisors Introduces a Strategic Alternative to Bankruptcy for End-of-Life Businesses
-
Top Technology Executives Recognized at the 2025 Tennessee ORBIE Awards
-
Just Blood Uncovers New Blood Testing Technology
-
Lineal Earns RelativityOne Data Migration Competency
-
Credit Repair Automate Launches to Simplify Credit Disputes Across Major Bureaus

